MedCity News October 1, 2025
Hackensack Meridian Health launched a clinical trial with Israeli startup SpotitEarly, which is developing a cancer test that combines AI with trained dogs to analyze patients’ breath. The study aims to validate this noninvasive approach alongside traditional screenings, potentially enabling earlier and more accessible cancer detection.
New Jersey-based health system Hackensack Meridian Health embarked on a cancer research study this week with Israeli diagnostics startup SpotitEarly.
The startup, which entered the U.S. market in May, is developing a test that uses AI and trained dogs to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages.
SpotitEarly’s test requires patients to breathe into what looks like an N95 mask for three minutes. After the sample is...
Today's Sponsors
Today's Sponsor